Latest Manufacturing News

PWR Holdings announces a pivotal leadership transition alongside the completion of its new global headquarters, reporting a transitional FY25 with mixed financial results but a confident outlook for FY26.

Iluka Resources reported steady Q3 production but announced suspension of synthetic rutile and Cataby mine operations from December 2025, aiming for significant cost savings. Meanwhile, rare earths refinery construction accelerates amid tightening Chinese export controls.

Iluka Resources has withdrawn its synthetic rutile sales guidance due to uncertainties stemming from Venator's sale and idling of its Greatham titanium dioxide facility. The move highlights growing market challenges and contract renegotiations in the pigment sector.

Orthocell has raised $30 million through an institutional placement to accelerate the US commercialisation of its flagship nerve repair product Remplir and expand its regenerative medicine portfolio.

Axel REE Limited has secured three new exploration licences adjacent to its Caladão Project in Brazil, launching a drilling campaign aimed at expanding its rare earth elements and gallium resources.

Structural Monitoring Systems (ASX – SMN) reports a robust third consecutive profitable quarter, driven by soaring avionics sales and a landmark US defense contract via Canada’s CCC program. Revenue climbs 23% year-on-year, signaling strong momentum in its Special Mission communications business.

Australian Finance Group Ltd (AFG) reported a robust 21% increase in net profit for FY25, driven by strategic broker network expansion and technology investments, while setting ambitious growth goals through FY29.

Talga Group and SQM have mutually terminated their joint venture for the Aero Project in Sweden due to regulatory delays, with Talga now exploring new partnership opportunities to advance the critical minerals project.

Mayne Pharma’s planned acquisition by Cosette Pharmaceuticals faces a delay as the Foreign Investment Review Board postpones its decision, potentially pushing back key court proceedings.

American West Metals has raised A$7 million at a premium to advance its West Desert Project, home to the largest and highest-grade indium resource in the US. The funding includes a strategic $2 million investment from Tribeca Investment Partners and aims to accelerate critical metals development amid supportive US policies.

Clarity Pharmaceuticals has inked a pivotal supply agreement with Nusano to ensure a steady source of copper-67, a critical isotope for its upcoming Phase III prostate cancer trial and future commercialisation plans.

TrivarX Limited has announced the acquisition of Stabl-Im, a novel stable isotope MRI technology for early brain tumor detection, backed by a $4.2 million capital raise including investment from biotech leader Dr Daniel Tillett.